Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Falutz

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|June 14, 2011
Growth hormone and HIV infection: contribution to disease manifestations and clinical implicationsJulian Falutz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2015
Editorial Commentary: Unmasking the Bare Bones of HIV Preexposure ProphylaxisJulian Falutz
Drugs of Today (Barcelona, Spain : 1998)|June 23, 2011
Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissueJulian Falutz
Current HIV/AIDS Reports|July 9, 2011
Management of fat accumulation in patients with HIV infectionJulian Falutz
Current Opinion in Clinical Nutrition and Metabolic Care|April 5, 2011
HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategiesJulian Falutz
Antiviral Therapy|November 25, 2017
Frailty: is thy name…..universal? Evolving challenges of managing effectively treated older people living with HIVJulian Falutz
Forum of Nutrition|April 6, 2005
Update on HIV/HAART associated morphologic and metabolic abnormalitiesJulian Falutz
Current HIV/AIDS Reports|May 13, 2020
Frailty in People Living with HIVJulian Falutz
Nature Clinical Practice. Endocrinology & Metabolism|August 22, 2007
Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapyJulian Falutz
Journal of Bone and Mineral Metabolism|December 24, 2004
Bone mineral and soft-tissue changes in AIDS-associated lipoatrophyLeonard Rosenthall, Julian Falutz
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Best Practice & Research. Clinical Endocrinology & Metabolism|June 14, 2011
Growth hormone and HIV infection: contribution to disease manifestations and clinical implicationsJulian Falutz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2015
Editorial Commentary: Unmasking the Bare Bones of HIV Preexposure ProphylaxisJulian Falutz
Drugs of Today (Barcelona, Spain : 1998)|June 23, 2011
Tesamorelin: a novel therapeutic option for HIV/HAART-associated increased visceral adipose tissueJulian Falutz
Current HIV/AIDS Reports|July 9, 2011
Management of fat accumulation in patients with HIV infectionJulian Falutz
Current Opinion in Clinical Nutrition and Metabolic Care|April 5, 2011
HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategiesJulian Falutz
Antiviral Therapy|November 25, 2017
Frailty: is thy name…..universal? Evolving challenges of managing effectively treated older people living with HIVJulian Falutz
Forum of Nutrition|April 6, 2005
Update on HIV/HAART associated morphologic and metabolic abnormalitiesJulian Falutz
Current HIV/AIDS Reports|May 13, 2020
Frailty in People Living with HIVJulian Falutz
Nature Clinical Practice. Endocrinology & Metabolism|August 22, 2007
Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapyJulian Falutz
Journal of Bone and Mineral Metabolism|December 24, 2004
Bone mineral and soft-tissue changes in AIDS-associated lipoatrophyLeonard Rosenthall, Julian Falutz
Pageof 7